✦ LIBER ✦

Therapeutic Monitoring of Isoniazid, Pyrazinamide and Rifampicin in Tuberculosis Patients Using LC

✍ Scribed by S. Unsalan; M. Sancar; B. Bekce; P. M. Clark; T. Karagoz; F. V. Izzettin; S. Rollas

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Isoniazid versus rifampicin and pyrazina

✍ R Colebunders; E Florence 📂 Article 📅 1998 🏛 The Lancet 🌐 English ⚖ 49 KB

Randomised trial of isoniazid versus rif

✍ Neal A Halsey; Jacqueline S Coberly; Julio Desormeaux; Phyllis Losikoff; Joan At 📂 Article 📅 1998 🏛 The Lancet 🌐 English ⚖ 131 KB

Hepatic toxicity in south indian patient

✍ R. Parthasarathy; G.Raghupati Sarma; B. Janardhanam; Padma Ramachandran; T. Sant 📂 Article 📅 1986 🏛 Elsevier Science 🌐 English ⚖ 893 KB

Population pharmacokinetics of rifampici

✍ Zvada, S. P.; Denti, P.; Donald, P. R.; Schaaf, H. S.; Thee, S.; Seddon, J. A.; 📂 Article 📅 2014 🏛 Oxford University Press 🌐 English ⚖ 589 KB

4-, 5- and 6-month regimens containing i

✍ S.L. Chan; P.C. Wong; C.M. Tam 📂 Article 📅 1994 🏛 Elsevier Science 🌐 English ⚖ 723 KB

Liquid chromatographic assay for the sim

✍ Jean Woo; C.L. Wong; R. Teoh; K. Chan 📂 Article 📅 1987 🏛 Elsevier Science ⚖ 575 KB